BRIEF published on 01/10/2025 at 13:05, 1 year ago Lumira Ventures Promotes Suman Rao to Principal Healthcare Innovation Venture Capital Lumira Ventures Suman Rao Principal Promotion
BRIEF published on 01/10/2025 at 13:05, 1 year ago Lumira Ventures promeut Suman Rao au poste de directeur Capital-risque Lumira Ventures Innovation Dans Le Domaine De La Santé Suman Rao Promotion Principale
PRESS RELEASE published on 01/10/2025 at 13:00, 1 year ago Lumira Ventures Announces Promotion of Suman Rao to Principal Lumira Ventures promotes Suman Rao, Ph.D., to Principal, recognizing her contributions to healthcare innovation. Read more about her journey and achievements Healthcare Innovation Venture Capital Lumira Ventures Biomedical Suman Rao
BRIEF published on 06/26/2024 at 13:05, 1 year 7 months ago Lumira Ventures Promotes Nikhil Thatte to Partner Promotion Life Sciences Lumira Ventures Healthcare Investment Nikhil Thatte
BRIEF published on 06/26/2024 at 13:05, 1 year 7 months ago Lumira Ventures promeut Nikhil Thatte comme partenaire Promotion Lumira Ventures Investissement Dans La Santé Sciences De La Vie Nikhil Thatte
PRESS RELEASE published on 06/26/2024 at 13:00, 1 year 7 months ago Lumira Ventures Announces Promotion of Nikhil Thatte to Partner Lumira Ventures promotes Nikhil Thatte to Partner in recognition of his exceptional contributions to healthcare innovation. Nikhil's strategic insights drive firm's success and partnerships Life Sciences Healthcare Innovation Lumira Ventures Investment Firm Nikhil Thatte
BRIEF published on 04/02/2024 at 13:05, 1 year 10 months ago Lumira Ventures Invests in Nocion Therapeutics to Advance Chronic Cough Treatment Lumira Ventures Nocion Therapeutics Chronic Cough Treatment Phase 2b Study Series B Financing
BRIEF published on 04/02/2024 at 13:05, 1 year 10 months ago Lumira Ventures investit dans Nocion Therapeutics pour faire progresser le traitement de la toux chronique Lumira Ventures Financement De Série B Nocion Thérapeutique Traitement De La Toux Chronique Étude De Phase 2b
PRESS RELEASE published on 04/02/2024 at 13:00, 1 year 10 months ago Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment Lumira Ventures invests in Nocion Therapeutics' Taplucanium for Chronic Cough treatment. Series B funding of $70M secured from leading investors Series B Funding Lumira Ventures Nocion Therapeutics Taplucanium Chronic Cough
BRIEF published on 03/07/2024 at 13:05, 1 year 10 months ago Lumira Ventures Celebrates Team Promotions Ahead of International Women's Day Healthcare Innovation Gender Equality International Women's Day Lumira Ventures Team Promotions
Published on 02/02/2026 at 15:00, 2 hours 49 minutes ago Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform
Published on 02/02/2026 at 14:30, 3 hours 19 minutes ago Unusual Machines Promotes Drew Camden to President
Published on 02/02/2026 at 14:30, 3 hours 19 minutes ago Predictiv AI Provides Pilot Update from Innovate Calgary's Soaring Higher Challenge with Calgary Airports and WestJet
Published on 02/02/2026 at 14:30, 3 hours 19 minutes ago NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres
Published on 02/02/2026 at 14:00, 3 hours 49 minutes ago Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio
Published on 02/02/2026 at 17:10, 38 minutes ago Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
Published on 02/02/2026 at 17:05, 43 minutes ago Lam Research and CEA-Leti Expand Research and Development Collaboration to Advance Fabrication of Specialty Technologies
Published on 02/02/2026 at 17:05, 44 minutes ago MPC Capital and Storm Capital launch MPC Storm Maritime Opportunities investment platform and raise USD 35 million in first close
Published on 02/02/2026 at 16:49, 59 minutes ago EQS-Adhoc: NORMA Group SE: Preparation of measures to repay inflows from the sale of the Water Management to shareholders, postponement of the 2026 Annual General Meeting and impairment of investments in EMEA
Published on 02/02/2026 at 16:15, 1 hour 33 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 02/02/2026 at 17:35, 14 minutes ago Disclosure of transactions in own shares from January 26 to January 30, 2026
Published on 02/02/2026 at 17:35, 14 minutes ago Déclaration hebdomadaire d'opérations effectuées du 26 au 30 Janvier 2026
Published on 02/02/2026 at 17:22, 27 minutes ago Statement of transactions in own shares from January 26, 2026 to January 30, 2026
Published on 02/02/2026 at 17:22, 27 minutes ago Déclaration des transactions sur actions propres réalisées du 26/01/2026 au 30/01/2026
